EEG Awareness Weeks – What EEG Can do for a Trial
The Siesta Group announces the "EEG Awareness Weeks" from Jan 7 to Mar 31, 2013. During this time The Siesta Group’s CEO Georg Dorffner and CSO Peter Anderer will hold free webinars on the topic "What EEG can do for a trial." A free feasibility analysis concerning efforts and costs of including EEG in an early or late phase trial to address CNS efficacy or safety of a drug will be offered to all participants.
• Thursday, Feb 14, 2013, 4pm GMT (11am EST)
• Friday, Mar 15, 2013, 3pm GMT (11am EDT)
The webinar is directed toward all clinical trial professionals who work on the development of CNS-active drugs and plan a new early or late phase clinical trial. Electroencephalography (EEG), including Event-Related Potentials (ERP), can be an objective endpoint of choice in many cases – this webinar will make clear why, when and with what benefit.
• Main EEG paradigms and endpoints
• Brain disorders and drug action as seen in the EEG
• The key-lock principle
• PD/PK modeling with EEG
• EEG topographies
• How The Siesta Group can support clinical trial EEG
Every participant will be entitled to receive a free feasibility and cost analysis about including EEG in a mock or real sample trial. Including EEG can be much more cost-effective than expected.
Interested persons can contact email@example.com for securing their webinar date and/or their personal analysis.
Mag. Katharina Glasner
+43 1 955 12 13